300702 Stock Overview
Engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Zhejiang Tianyu Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥16.25 |
| 52 Week High | CN¥23.89 |
| 52 Week Low | CN¥13.16 |
| Beta | -0.011 |
| 11 Month Change | -5.74% |
| 3 Month Change | 15.33% |
| 1 Year Change | -30.64% |
| 33 Year Change | -63.40% |
| 5 Year Change | n/a |
| Change since IPO | -46.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300702 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | -2.1% |
| 1Y | -30.6% | -9.4% | 2.8% |
Return vs Industry: 300702 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 300702 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 300702 volatility | |
|---|---|
| 300702 Average Weekly Movement | 7.8% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300702 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300702's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 4,690 | Yong Jun Tu | www.tianyupharm.com |
Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of cardiovascular, anti-diabetic, anti-atherosclerosis, anticoagulant, and anti-asthmatic series. It provides fine chemicals and CDMO services.
Zhejiang Tianyu Pharmaceutical Co., Ltd. Fundamentals Summary
| 300702 fundamental statistics | |
|---|---|
| Market cap | CN¥5.59b |
| Earnings (TTM) | CN¥43.68m |
| Revenue (TTM) | CN¥2.59b |
128.0x
P/E Ratio2.2x
P/S RatioIs 300702 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300702 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.59b |
| Cost of Revenue | CN¥1.75b |
| Gross Profit | CN¥846.19m |
| Other Expenses | CN¥802.51m |
| Earnings | CN¥43.68m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 32.61% |
| Net Profit Margin | 1.68% |
| Debt/Equity Ratio | 47.6% |
How did 300702 perform over the long term?
See historical performance and comparison